Table 5. Comparison between prior antibiotic therapy during the first week of illness and no prior antibiotics with infectious complications.
ICU: intensive care unit; MDR: multi-drug resistance *P-values <0.05 are considered significant.
Parameters | Patients with prior antibiotic exposure in the first week (N=38) | Patients with no prior antibiotic exposure in the first week (N=92) | p-value |
Infected necrosis (pancreatic(peri) infection), n(%) | 15 (39.47%) | 24 (26.08%) | 0.128 |
Extrapancreatic infections, n(%) | 8 (21.05%) | 12 (13.04%) | 0.164 |
Combined infection, n(%) | 19 (50%) | 17 (18.47%) | 0.001* |
MDR organisms, n(%) | 24 (63.15%) | 22 (23.91%) | <0.001* |
Fungal infection, n(%) | 4 (10.52%) | 2 (2.1%) | 0.012* |
Need for intervention, n (%) | 26(68.42%) | 62(67.3%) | 0.254 |
Need for surgery, n (%) | 10(26.3%) | 8(8.6%) | 0.066* |
Need for ICU, n (%) | 25(65.78%) | 30(32.60%) | 0.002* |
Mortality, n (%) | 15(39.47%) | 13(14.13%) | 0.018* |